Summary.After oral administration, dipeptide Phe-Phe-OMe 1 exhibits anthelmintic activity against Echinococcus multilocularis larvae, cestoda, in mongolian gerbils (intraperitoneal localization), but not against Hymenolepis nana, cestoda, in fasted mice (gastro-intestinal localization). This compound rapidly provides its cyclization product dioxopiperazine 2 in pH 7.4 buffer at 37°C, but was stable at pH 2.4 during 16h at 30°C. It was postulated that dipeptide 1 could act as a prodrug of 2. Initial pharmacokinetics studies were carried out in mice and dogs. After oral administration, biotransformation of 1 into 2 occurred to some extent in mice but not in fasted dogs. Results of these studies did not allow to ascertain that 1 is a prodrug of 2. Compound 2 has been tested in mice against H. nana and Schistosoma rnansoni, a gastrointestinal trematoda. Albeit less active than the reference compound praziquantel, 2 has shown a good activity against both worms. 2,5-dioxopiperazines represent therefore a new class of anthelmintics.